🔎 Trials Near Me

Hem › Crohns sjukdom › Florida › Orlando

Kliniska studier för Crohns sjukdom i Orlando, FL

17 studier för Crohns sjukdom söker deltagare vid platser i och runt Orlando (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

RekryterarFas 2
  • Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
  • Clinical Research of Osceola /ID# 280593, Kissimmee · 16 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 5 okt. 2026 · NCT07697456

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RekryterarFas 3
  • AdventHealth Orlando ( Site 5131), Orlando
  • Endoscopic Research Inc ( Site 5061), Orlando
Ålder 16 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

RekryterarFas 4
  • Endoscopic Research, Inc., Orlando
  • Orlando Health-Orlando Regional Medical Center, Orlando
  • Digestive and Liver Center of Florida, P.A., Kissimmee · 16 mi bort
Ålder 18 till 80 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

RekryterarFas 2
  • Endoscopic Research, Inc. /ID# 267211, Orlando
  • Novum Research /ID# 278128, Clermont · 24 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06548542

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 2
  • AdventHealth (Florida Hospital) Medical Group, Orlando
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06233461

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

RekryterarFas 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Ålder 18 till 70 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 3
  • AdventHealth Orlando-Site Number: 8400070, Orlando
  • Orlando Health, Inc.-Site Number: 8400084, Orlando
  • Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 mi bort
  • och 1 fler
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 3
  • Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084, Orlando
  • Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 mi bort
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184944

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 3
  • Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
Ålder 2 till 17 · Alla kön · Uppdaterad 23 sep. 2026 · NCT05995353

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

RekryterarFas 2
  • Endoscopic Research Inc, Orlando
  • Clinical Research of Osceola, Kissimmee · 16 mi bort
Ålder 18 till 85 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06226883

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

RekryterarFas 4
  • Endoscopic Research Inc, Orlando
  • Clinical Research of Osceola, Kissimmee · 16 mi bort
Ålder 18 till 70 · Alla kön · Uppdaterad 9 sep. 2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Rekryterar
  • Advent Health, Orlando
Ålder 18 och äldre · Alla kön · Uppdaterad 7 aug. 2026 · NCT05230173

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

RekryterarObservationsstudie
  • AdventHealth, Orlando
Ålder 18 och äldre · Alla kön · Uppdaterad 5 aug. 2026 · NCT07237516

Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD

RekryterarFas 4
  • Digestive & Liver Center of Florida, Orlando
Ålder 18 och äldre · Alla kön · Uppdaterad 16 juli 2026 · NCT06997965

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

RekryterarFas 2
  • Orlando Health, Inc., Orlando
Ålder 18 till 75 · Alla kön · Uppdaterad 27 apr. 2026 · NCT06456593

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

RekryterarFas 2
  • Investigational Site Number: 8400007, Orlando
  • Investigational Site Number: 8400017, Kissimmee · 16 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 27 mars 2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RekryterarFas 2
  • Mirador Therapeutics Selected Site, Orlando
Ålder 18 till 80 · Alla kön · Uppdaterad 12 mars 2026 · NCT07113522

Crohns sjukdom-studier i andra städer

Andra studier i Orlando

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.